Clara Hwang

Title: Clara Hwang - Innovator in Pharmaceutical Treatments

Introduction

Clara Hwang is a notable inventor based in Wilmington, Delaware. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of patients at risk for developing NSAID-associated ulcers. Her innovative approach has the potential to improve patient outcomes and enhance the quality of care.

Latest Patents

Clara Hwang holds a patent for a method aimed at treating a disease or disorder in patients at risk of developing NSAID-associated ulcers. The patent describes a pharmaceutical composition in unit dose form that includes naproxen and esomeprazole, or their pharmaceutically acceptable salts. This method is designed to decrease the risk of ulcer development in at-risk patients, showcasing her commitment to advancing medical treatments.

Career Highlights

Throughout her career, Clara has worked with reputable companies such as Pozen Inc. and Horizon Pharma USA, Inc. Her experience in these organizations has allowed her to collaborate with other professionals in the field and contribute to groundbreaking research and development.

Collaborations

Clara has collaborated with notable coworkers, including Brian Ault and Everardus Orlemans. These partnerships have played a crucial role in her innovative work and have helped to foster a collaborative environment in the pharmaceutical industry.

Conclusion

Clara Hwang's contributions to the field of pharmaceuticals, particularly through her patent for treating NSAID-associated ulcers, highlight her role as an influential inventor. Her work continues to impact patient care positively and demonstrates the importance of innovation in medicine.